Adoption of a resolution by the Company's Management Board concerning the issuance of shares as part of an authorized share capital increase

Current Report No. 13/2022

Date of preparation: 27 April 2022

Subject: Adoption of a resolution by the Company's Management Board concerning the issuance of shares as part of an authorized share capital increase

Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company"), informs that on 27 April 2022 the Company's Management Board adopted a resolution about an issuance of 9,420 series L ordinary bearer shares under the Company's authorized share capital, excluding subscription rights of the existing shareholders in full.

The issuance is related to the implementation of the Company's share-based incentive program for employees. Attached is the text of the adopted resolution.